Johnson & Johnson
5 Feb 2021
European nations need to work more closely with drug firms to increase the pace of coronavirus inoculations, the WHO said on Friday, as Johnson & Johnson pushed for its jab to become the third approved for use in the United States.
5 Aug 2020
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
5 Mar 2020
A consortium of philanthropic, non-profit and private sector organisations have launched a collaboration that aims to accelerate the development of novel “pan-TB” drug regimens
15 Dec 2018
In line with the theme Repositioning Healthcare in Africa for Sustainable Development, global brand Johnson & Johnson has announced the second edition of Africa...
16 May 2018
Pharmaceutical giant Johnson & Johnson announced on May 2, 208 that it would pay up to US$1 billion to acquire a company that makes cancer-killing viruses. It was a striking show of support for a still-unproven treatment, but the bid is just the latest sign that industry and academics are warming to the approach. In…
28 Mar 2018
Scientists gathering at the Kigali Convention Centre, Rwanda for the Next Einstein Forum (NEF), yesterday said science journalism in Africa had potentials to drive the...
4 Sep 2017
The California jury's decision marks the largest award yet in a string of lawsuits that claim the firm did not adequately warn about cancer risks from talc-based products.
30 Aug 2017
Johnson & Johnson has been ordered to pay $417m (£323.4m) to a woman who says she developed ovarian cancer after using products such as baby powder.